We found that treatment with SIRT1 agonists, given in a therapeutic window of time after Trypanosoma cruzi infection, had no beneficial effects in reducing the cardiac remodeling and mitochondrial biogenic defects in chagasic mice. Here, SIRT1 is linked to Chagas disease.